201 related articles for article (PubMed ID: 34196912)
1. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
Lipreri da Silva JC; Coelho-Silva JL; Lima K; Vicari HP; Lazarini M; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2021 Oct; 44(5):1105-1117. PubMed ID: 34196912
[TBL] [Abstract][Full Text] [Related]
2. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells.
Lipreri da Silva JC; Carvalho MFL; de Miranda LBL; de Almeida BO; Lima K; Machado-Neto JA
Invest New Drugs; 2022 Aug; 40(4):728-737. PubMed ID: 35477813
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.
Bulut G; Hong SH; Chen K; Beauchamp EM; Rahim S; Kosturko GW; Glasgow E; Dakshanamurthy S; Lee HS; Daar I; Toretsky JA; Khanna C; Uren A
Oncogene; 2012 Jan; 31(3):269-81. PubMed ID: 21706056
[TBL] [Abstract][Full Text] [Related]
4. Ezrin Inhibition Up-regulates Stress Response Gene Expression.
Çelik H; Bulut G; Han J; Graham GT; Minas TZ; Conn EJ; Hong SH; Pauly GT; Hayran M; Li X; Özdemirli M; Ayhan A; Rudek MA; Toretsky JA; Üren A
J Biol Chem; 2016 Jun; 291(25):13257-70. PubMed ID: 27137931
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia.
Puente-Moncada N; Costales P; Antolín I; Núñez LE; Oro P; Hermosilla MA; Pérez-Escuredo J; Ríos-Lombardía N; Sanchez-Sanchez AM; Luño E; Rodríguez C; Martín V; Morís F
Mol Cancer Ther; 2018 Mar; 17(3):614-624. PubMed ID: 29339551
[TBL] [Abstract][Full Text] [Related]
6.
Bai H; Zhou M; Zeng M; Han L
DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.
Çelik H; Hong SH; Colón-López DD; Han J; Kont YS; Minas TZ; Swift M; Paige M; Glasgow E; Toretsky JA; Bosch J; Üren A
Mol Cancer Ther; 2015 Nov; 14(11):2497-507. PubMed ID: 26358752
[TBL] [Abstract][Full Text] [Related]
8. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
9. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
10. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X
Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742
[TBL] [Abstract][Full Text] [Related]
12. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis.
Carlos JAEG; Lima K; Costa-Lotufo LV; Leitão A; Machado-Neto JA
Invest New Drugs; 2021 Aug; 39(4):1139-1149. PubMed ID: 33475938
[TBL] [Abstract][Full Text] [Related]
13. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
[TBL] [Abstract][Full Text] [Related]
14. Phagocytosis and Motility in Human Neutrophils is Competent but Compromised by Pharmacological Inhibition of Ezrin Phosphorylation.
Roberts RE; Elumalai GL; Hallett MB
Curr Mol Pharmacol; 2018; 11(4):305-315. PubMed ID: 29766831
[TBL] [Abstract][Full Text] [Related]
15. High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients.
Zhang R; Zhang S; Xing R; Zhang Q
Thorac Cancer; 2019 Oct; 10(10):1953-1961. PubMed ID: 31452341
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway.
Cheng H; Ding J; Tang G; Huang A; Gao L; Yang J; Chen L
Mol Med; 2021 Oct; 27(1):128. PubMed ID: 34656078
[TBL] [Abstract][Full Text] [Related]
17. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia.
Lipreri da Silva JC; Saldanha-Araujo F; de Melo RCB; Vicari HP; Silva-Carvalho AE; Rego EM; Buccheri V; Machado-Neto JA
Life Sci; 2022 Dec; 311(Pt B):121146. PubMed ID: 36336127
[TBL] [Abstract][Full Text] [Related]
18. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract][Full Text] [Related]
19. SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia.
Lv G; Wang Y; Ji C; Shi C; Li Y
Hematology; 2022 Dec; 27(1):1-10. PubMed ID: 34957932
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia.
Raponi M; Belly RT; Karp JE; Lancet JE; Atkins D; Wang Y
BMC Cancer; 2004 Aug; 4():56. PubMed ID: 15329151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
